Dr Erin Bohula (Brigham and Women's Hospital, Boston, US) discusses CAMELLIA-TIMI 61 - a study to evaluate the effect of long-term treatment with BELVIQ (Lorcaserin HCl) on the incidence of MACE and conversion to type 2 diabetes mellitus in obese and overweight subjects with CVD or multiple CV risk factors.

Filmed on-site at ESC 2018.